Zai Lab Limited (ZLAB) Reports Acceptance of NDA Submission of ZEJULA (Niraparib) in Mainland China by the NMPA
Tweet Send to a Friend
Zai Lab Limited (NASDAQ: ZLAB) today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
